ProShares UltraPro Nasdaq Biotechnology (UBIO)

Add to Watchlists
Create an Alert
41.29 +0.84  +2.08% NASDAQ Jul 17, 16:59 Delayed 2m USD
View Full Chart
UBIO Price Chart
View All UBIO News

UBIO News

UBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 16.94% 16.61% -- --
3M 34.74% 34.68% -- --
6M 8.88% 8.92% -- --
YTD 20.24% 20.18% -- --
1Y 19.96% 19.97% -- --
3Y -28.08% -28.08% -- --
5Y -- -- -- --
10Y -- -- -- --
As of July 16, 2018. Returns for periods of 1 year and above are annualized.

UBIO Asset Allocation

Type % Net % Long % Short
Cash -200.5% 25.26% 225.7%
Stock 74.74% 74.74% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 225.7% 225.7% 0.00%
As of June 30, 2018
View More Holdings

UBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Ubs Ag 130.8% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America Na 59.82% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 29.55% -- --
GILD Gilead Sciences Inc 6.20% 77.30 +0.05%
AMGN Amgen Inc 6.06% 193.93 -0.49%
BIIB Biogen Inc 5.82% 354.91 +0.53%
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 5.55% -- --
CELG Celgene Corp 5.50% 85.86 +0.74%
ILMN Illumina Inc 3.93% 305.52 +1.17%
REGN Regeneron Pharmaceuticals Inc 3.39% 365.45 +0.19%
As of June 30, 2018
Advertisement

UBIO Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
300.0%

UBIO Manager Info

Name Tenure
Devin Sullivan 1.67 yrs
Michael Neches 2.94 yrs
Tarak Davé 0.09 yrs

UBIO Net Fund Flows

1M -4.986M
3M -2.341M
6M -14.08M
YTD -14.08M
1Y -10.42M
3Y 43.76M
5Y --
10Y --
As of June 30, 2018

UBIO Risk Info

Beta (5Y) --
Max Drawdown (All) 84.16%
Historical Sharpe (10Y) --
Historical Sortino (All) -0.182
30-Day Rolling Volatility 54.61%
Daily Value at Risk (VaR) 1% (All) 12.39%
Monthly Value at Risk (VaR) 1% (All) 49.82%

UBIO Comparables

Edit

UBIO Attributes

Key Dates
Inception Date 6/22/2015
Termination Date
Last Annual Report Date 5/31/2017
Last Prospectus Date 10/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

UBIO Excel Add-In Codes

  • Name: =YCI("UBIO","name")
  • Broad Asset Class: =YCI("UBIO", "broad_asset_class")
  • Broad Category: =YCI("UBIO", "broad_category_group")
  • Prospectus Objective: =YCI("UBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.